Who is affected by chondrosarcoma?

This information has been written for patients, their families and friends, and the general public to help them understand more about chondrosarcoma: what it is and the different types. This information is produced in accordance with BCRT's information policy.

Chondrosarcoma can affect people of all ages but is mostly found in adults between the ages of 30 and 60 years. 80% of cases are in people aged 40 years or older.

(Lor Randal et al., 2010, Kim et al., 2011, Kleihues et al., 2006, Hogendoorn et al., 2010, Ryzewicz et al., 2007, Whelan et al 2011 ).

  • Chondrosarcoma is the most common form of primary bone cancer
    (West Midlands Cancer Intelligence Unit 2011, National Cancer Registry of Ireland 2010, Kleihues et al. 2006, NCIN 2012)

  • The incidence rate in England is around 2.9 people affected per 1 million people of the population.
    (NCIN 2012)

  • In the UK there are around 190 new cases of chondrosarcoma diagnosed each year.
    (NCIN 2012, National Cancer Registry of Ireland 2010)

  • In The Republic of Ireland there are around 12 new cases of chondrosarcoma diagnosed each year.
    (Data from National Cancer Registry of Ireland)

Conventional chondrosarcoma

  • Mostly found in adults over the age of 50 years.
  • Males are affected slightly more than females
  • Conventional chondrosarcoma accounts for 75% of chondrosarcoma cases.

(Lewis and Gloeckler Ries, 2011, Hogendoorn et al., 2010).

Dedifferentiated chondrosarcoma

  • The average age at presentation is between 50 and 60 years.
  • Males and females appear to be affected equally.

(Kim et al., 2011, Grimer et al., 2007, Mitchel et al., 2000, Kleihues et al., 2006)

Mesenchymal chondrosarcoma

  • Can occur at any age but has a peak incidences in teens and young adults.
  • Males and females appear to be affected equally.

(Lor Randal, 2010, Kim et al., 2011, Nakashima et al., 1986, Kleihues et al., 2006)

Clear cell chondrosarcoma

  • Can occur at any age but peak incidence is in 30s and 40s.
  • Males are more commonly affected than females (~ 2.5: 1).

(Kim et al., 2011, Goldenblom et al., 2008, Kleihues et al., 2006)

The authors and reviewers of this information are committed to producing reliable, accurate and up to date content reflecting the best available research evidence, and best clinical practice. We aim to provide unbiased information free from any commercial conflicts of interest. This article is for information only and should not be used for the diagnosis or treatment of medical conditions. BCRT can answer questions about primary bone cancers, including treatments and research but we are unable to offer specific advice about individual patients. If you are worried about any symptoms please consult your doctor.

The Information Standard Disclaimer
BCRT shall hold responsibility for the accuracy of the information they publish and neither the Scheme Operator nor the Scheme Owner shall have any responsibility whatsoever for costs, losses or direct or indirect damages or costs arising from inaccuracy of information or omissions in information published on the website on behalf of BCRT.

Version 2 produced January 2013
Information will be reviewed in January 2015

Social Networks
Follow us on Twitter
We're awarding 5 x £10k research grants at our Strictly Research 10th birthday celebrations. More info on the flyer: https://t.co/ESFcJKVrcU
View us on Flickr
Join us on Facebook
The Information Standard - Certified Member